Physician
Fleming, Sara
Fleming, Sara was paid $13.03M by Medicaid between Jan 2018 and Dec 2024, across 236 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 11% of everything it billed.
33Billing provider infoFLEMING, SARA
ROCKFORD, IL 61104
ROCKFORD, IL 61104
33aNPI1972575157assigned 02/02/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$13.03M
24GClaims1,936,239
24DCodes billed236
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#2 of 398
Median peer was paid$66K
This provider vs. median198×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 159,972 | $974K | |
| 2019 | 237,077 | $1.38M | |
| 2020 | 298,789 | $1.50M | |
| 2021 | 374,795 | $2.68M | |
| 2022 | 339,614 | $2.68M | |
| 2023 | 295,871 | $2.11M | |
| 2024incomplete | 230,121 | $1.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 37,735 | 31,117 | $1.40M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.4% | 36,885 | 29,880 | $963K |
| 80053 | Comprehensive metabolic panel | 6.7% | 169,723 | 113,278 | $875K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.7% | 27,668 | 25,639 | $617K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.7% | 27,611 | 25,603 | $616K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.9% | 175,874 | 116,229 | $508K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.5% | 5,746 | 5,418 | $455K |
| 87632 | 3.3% | 4,953 | 4,355 | $433K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.9% | 46,606 | 39,064 | $382K |
| 82805 | 2.4% | 12,866 | 7,513 | $313K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.9% | 61,412 | 31,901 | $253K |
| 83735 | 1.8% | 69,363 | 36,035 | $237K |
224 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.8% | 45,153 | $231K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.7% | 8,410 | $222K |
| 85027 | 1.7% | 76,823 | $221K | |
| 87641 | 1.5% | 9,167 | $199K | |
| 84484 | 1.5% | 43,289 | $198K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 9,495 | $188K |
| 83880 | 1.4% | 15,793 | $178K | |
| 87040 | 1.3% | 15,530 | $174K | |
| 83605 | 1.3% | 27,547 | $165K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.0% | 3,742 | $131K |
| 82962 | <1% | 63,697 | $130K | |
| 80061 | Lipid panel | <1% | 33,775 | $117K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 36,635 | $115K |
| 83690 | <1% | 32,030 | $108K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15,350 | $105K |
| 86703 | <1% | 10,754 | $105K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,896 | $105K |
| 87186 | <1% | 14,797 | $93K | |
| 85610 | <1% | 44,178 | $89K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 5,801 | $82K |
| 87653 | <1% | 3,642 | $82K | |
| 82607 | <1% | 13,786 | $82K | |
| 86901 | <1% | 32,219 | $72K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,223 | $69K |
| 86850 | <1% | 23,286 | $67K | |
| 82746 | <1% | 11,731 | $67K | |
| 87081 | <1% | 23,304 | $66K | |
| 86803 | <1% | 7,962 | $66K | |
| 81001 | <1% | 45,930 | $62K | |
| 82728 | <1% | 15,616 | $61K | |
| 85730 | <1% | 18,959 | $59K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,065 | $55K |
| 87340 | <1% | 8,106 | $54K | |
| 83498 | <1% | 6,331 | $50K | |
| 82261 | <1% | 6,155 | $50K | |
| 84439 | <1% | 11,021 | $48K | |
| 86003 | <1% | 2,214 | $48K | |
| 86900 | <1% | 28,285 | $48K | |
| 83021 | <1% | 7,755 | $48K | |
| 81025 | <1% | 22,550 | $47K | |
| 83516 | <1% | 8,931 | $43K | |
| 84100 | <1% | 16,944 | $43K | |
| 84702 | <1% | 9,171 | $42K | |
| 82775 | <1% | 6,113 | $42K | |
| 87210 | <1% | 19,624 | $41K | |
| 87634 | <1% | 1,590 | $40K | |
| 82330 | <1% | 3,700 | $39K | |
| 85379 | <1% | 9,995 | $37K | |
| 82139 | <1% | 6,190 | $37K | |
| 82803 | <1% | 1,388 | $36K | |
| 83550 | <1% | 8,437 | $36K | |
| 82017 | <1% | 6,139 | $36K | |
| 87449 | <1% | 3,107 | $35K | |
| 88307 | <1% | 441 | $35K | |
| 86706 | <1% | 4,707 | $32K | |
| 83655 | <1% | 5,456 | $31K | |
| 86141 | <1% | 3,822 | $31K | |
| 86592 | <1% | 15,569 | $31K | |
| 81003 | <1% | 30,063 | $31K | |
| 83540 | <1% | 9,175 | $29K | |
| 86704 | <1% | 3,735 | $29K | |
| 83970 | <1% | 1,709 | $27K | |
| 81511 | <1% | 530 | $26K | |
| 82570 | <1% | 11,231 | $26K | |
| 82550 | <1% | 7,996 | $25K | |
| 87522 | Neg quan hep c or qual rna | <1% | 927 | $25K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,067 | $25K |
| 86038 | <1% | 3,148 | $24K | |
| 84146 | <1% | 3,171 | $21K | |
| 87070 | <1% | 6,694 | $21K | |
| 86140 | <1% | 8,856 | $21K | |
| 83874 | <1% | 3,715 | $20K | |
| 82784 | <1% | 2,768 | $19K | |
| 84437 | <1% | 6,066 | $19K | |
| 80074 | <1% | 947 | $18K | |
| 87807 | <1% | 3,589 | $18K | |
| 82247 | <1% | 7,737 | $18K | |
| 82553 | <1% | 4,701 | $17K | |
| 86708 | <1% | 3,535 | $17K | |
| 80202 | <1% | 2,468 | $16K | |
| 82248 | <1% | 7,283 | $16K | |
| 85007 | <1% | 9,331 | $16K | |
| 80076 | <1% | 4,223 | $16K | |
| 84145 | <1% | 1,125 | $15K | |
| 86880 | <1% | 4,928 | $15K | |
| 87536 | <1% | 364 | $15K | |
| 87902 | <1% | 190 | $14K | |
| 82043 | <1% | 6,460 | $14K | |
| 84153 | <1% | 2,152 | $14K | |
| 86762 | <1% | 3,283 | $14K | |
| 82105 | <1% | 1,669 | $14K | |
| 87205 | <1% | 7,213 | $13K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 943 | $13K |
| 82565 | <1% | 6,133 | $13K | |
| 87806 | <1% | 1,327 | $13K | |
| 85652 | <1% | 9,835 | $13K | |
| 83615 | <1% | 4,563 | $13K | |
| 85520 | <1% | 2,615 | $13K | |
| 87529 | <1% | 345 | $12K | |
| 84481 | <1% | 2,421 | $12K | |
| 80069 | <1% | 3,012 | $12K | |
| 87077 | <1% | 5,416 | $12K | |
| 82140 | <1% | 2,626 | $12K | |
| 87075 | <1% | 1,829 | $11K | |
| 84403 | <1% | 867 | $11K | |
| 88342 | <1% | 525 | $10K | |
| 84132 | <1% | 5,001 | $10K | |
| 83001 | <1% | 1,107 | $10K | |
| 82533 | <1% | 1,390 | $10K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 232 | $10K |
| 86481 | <1% | 351 | $10K | |
| 80051 | <1% | 2,810 | $9K | |
| 82950 | <1% | 3,492 | $8K | |
| 87324 | <1% | 1,089 | $8K | |
| 86376 | <1% | 1,763 | $8K | |
| 82947 | <1% | 3,848 | $7K | |
| 89051 | <1% | 1,493 | $7K | |
| 82150 | <1% | 2,146 | $7K | |
| 87427 | <1% | 1,114 | $7K | |
| 84460 | <1% | 3,070 | $7K | |
| 86787 | <1% | 828 | $6K | |
| 86870 | <1% | 791 | $6K | |
| 87045 | <1% | 902 | $6K | |
| 84450 | <1% | 2,412 | $5K | |
| 84156 | <1% | 4,752 | $5K | |
| 87631 | <1% | 106 | $5K | |
| 82785 | <1% | 1,211 | $5K | |
| 85014 | <1% | 3,553 | $5K | |
| 84295 | <1% | 1,483 | $5K | |
| 85018 | <1% | 4,876 | $5K | |
| 87184 | <1% | 1,104 | $5K | |
| 84480 | <1% | 1,097 | $5K | |
| 84520 | <1% | 2,560 | $5K | |
| 86696 | <1% | 452 | $5K | |
| 84550 | <1% | 2,137 | $4K | |
| 84270 | <1% | 520 | $4K | |
| 85384 | <1% | 1,258 | $4K | |
| 82274 | <1% | 784 | $4K | |
| 87338 | <1% | 418 | $4K | |
| 86430 | <1% | 1,199 | $4K | |
| 85045 | <1% | 2,838 | $4K | |
| 84075 | <1% | 1,488 | $3K | |
| 82009 | <1% | 2,581 | $3K | |
| 82977 | <1% | 1,293 | $3K | |
| 80197 | <1% | 607 | $3K | |
| 83721 | <1% | 796 | $3K | |
| 88304 | <1% | 151 | $3K | |
| 81002 | <1% | 2,648 | $3K | |
| 83883 | <1% | 411 | $3K | |
| 87046 | <1% | 917 | $3K | |
| 83002 | <1% | 544 | $3K | |
| 82378 | <1% | 417 | $3K | |
| 80164 | <1% | 602 | $3K | |
| 83930 | <1% | 1,109 | $3K | |
| 86922 | <1% | 268 | $3K | |
| 84478 | <1% | 1,029 | $2K | |
| 84300 | <1% | 1,169 | $2K | |
| 86308 | <1% | 1,038 | $2K | |
| 84144 | <1% | 265 | $2K | |
| 80050 | General health panel | <1% | 3,701 | $2K |
| 82465 | <1% | 1,101 | $2K | |
| 88341 | <1% | 71 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 13 | $2K |
| 80055 | <1% | 122 | $2K | |
| 83993 | <1% | 273 | $2K | |
| 82040 | <1% | 774 | $2K | |
| 86777 | <1% | 221 | $1K | |
| 83013 | <1% | 143 | $1K | |
| 86255 | <1% | 372 | $1K | |
| 83718 | <1% | 359 | $1K | |
| 86694 | <1% | 125 | $1K | |
| 82951 | <1% | 189 | $1K | |
| 80177 | <1% | 250 | $1K | |
| 85049 | <1% | 978 | $1K | |
| 82670 | <1% | 156 | $1K | |
| 86800 | <1% | 197 | $1K | |
| 83525 | <1% | 255 | $1K | |
| 86695 | <1% | 146 | $1K | |
| 83935 | <1% | 451 | $1K | |
| 86360 | <1% | 231 | $1K | |
| 86778 | <1% | 114 | $996.40 | |
| 86256 | <1% | 151 | $962.70 | |
| 84703 | <1% | 203 | $723.16 | |
| 87109 | <1% | 156 | $703.17 | |
| 87102 | <1% | 196 | $641.70 | |
| 86359 | <1% | 227 | $637.94 | |
| 86147 | <1% | 52 | $608.22 | |
| 80438 | <1% | 23 | $567.64 | |
| 85460 | <1% | 242 | $544.55 | |
| 84436 | <1% | 167 | $538.95 | |
| 86235 | <1% | 25 | $519.20 | |
| 84402 | <1% | 49 | $455.35 | |
| 86905 | <1% | 181 | $454.70 | |
| 82272 | <1% | 336 | $433.17 | |
| 86885 | <1% | 135 | $411.75 | |
| 82103 | <1% | 90 | $402.93 | |
| 86361 | <1% | 82 | $388.00 | |
| 86039 | <1% | 77 | $385.20 | |
| 84425 | <1% | 57 | $365.37 | |
| 80185 | <1% | 46 | $337.48 | |
| 86304 | <1% | 30 | $325.50 | |
| 86480 | <1% | 14 | $312.36 | |
| 87581 | <1% | 13 | $297.70 | |
| 87486 | <1% | 13 | $297.70 | |
| 82390 | <1% | 49 | $217.07 | |
| 80305 | <1% | 47 | $206.42 | |
| 84157 | <1% | 163 | $203.07 | |
| 85347 | <1% | 63 | $178.10 | |
| 80178 | <1% | 52 | $177.65 | |
| 82310 | <1% | 90 | $175.58 | |
| 84080 | <1% | 39 | $172.77 | |
| 82945 | <1% | 75 | $118.58 | |
| 83520 | <1% | 19 | $115.38 | |
| 86765 | <1% | 24 | $102.50 | |
| 84154 | <1% | 12 | $79.20 | |
| 86735 | <1% | 12 | $76.20 | |
| 82104 | <1% | 16 | $66.40 | |
| 82575 | <1% | 13 | $59.93 | |
| 82627 | <1% | 16 | $56.68 | |
| 86225 | <1% | 13 | $53.10 | |
| 85008 | <1% | 45 | $51.03 | |
| 84160 | <1% | 33 | $49.72 | |
| 82042 | <1% | 15 | $34.95 | |
| 86923 | 0% | 842 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.